Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
CTNM.OQ - Contineum Therapeutics Inc
Contineum Therapeutics Inc at RBC Capital Markets Global Healthcare Conference
May 19, 2026 / 07:35PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Joining us for this next session. My name is Nevin Varghese. I'm one of the analysts at RBC Capital Markets.
Thank you for joining us today. We have with us Carmine Stangone, who's the President and CEO of Continuum Therapeutics. Carmine, thank you for being with us. Thanks for the invite.
So, diving right into it, we've seen some data recently.
I think. Some of the data that we saw recently from pain was particularly intriguing. So, I'm wondering if you can touch on that a little bit more, just given that, some of the Phase 1B chronic pain data that we saw showed promising trends in pain reduction and responder rates.
This was supposed to be exploratory,
Trustpilot
